instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'CHORIOGONADOTROPIN ALFA'? | Severe late-onset ovarian hyperstimulation syndrome presenting with liver dysfunction after in vitro fertilization: A case report.
Ovarian hyperstimulation syndrome (OHSS) is a feared complication of controlled ovarian stimulation (COS) and can be associated with significant morbidity and mortality. Risk factors for OH... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34159057 | 19,719,749 | 2021-07 |
What was the outcome of reaction 'Maternal exposure before pregnancy'? | Severe late-onset ovarian hyperstimulation syndrome presenting with liver dysfunction after in vitro fertilization: A case report.
Ovarian hyperstimulation syndrome (OHSS) is a feared complication of controlled ovarian stimulation (COS) and can be associated with significant morbidity and mortality. Risk factors for OH... | Recovered | ReactionOutcome | CC BY-NC-ND | 34159057 | 19,719,749 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acquired immunodeficiency syndrome'. | Infected Aneurysm of the Native Aorta due to Coccidioides posadasii.
Coccidioidomycosis is an endemic fungal infection that is typically asymptomatic or associated with pulmonary disease. Extrapulmonary disease may involve the skin, bones, or central nervous system, yet endovascular infections are exceedingly rare. We ... | LAMIVUDINE, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC-ND | 34159219 | 20,322,682 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coccidioidomycosis'. | Infected Aneurysm of the Native Aorta due to Coccidioides posadasii.
Coccidioidomycosis is an endemic fungal infection that is typically asymptomatic or associated with pulmonary disease. Extrapulmonary disease may involve the skin, bones, or central nervous system, yet endovascular infections are exceedingly rare. We ... | LAMIVUDINE, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC-ND | 34159219 | 20,322,682 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary mass'. | Infected Aneurysm of the Native Aorta due to Coccidioides posadasii.
Coccidioidomycosis is an endemic fungal infection that is typically asymptomatic or associated with pulmonary disease. Extrapulmonary disease may involve the skin, bones, or central nervous system, yet endovascular infections are exceedingly rare. We ... | LAMIVUDINE, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC-ND | 34159219 | 20,322,682 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment noncompliance'. | Infected Aneurysm of the Native Aorta due to Coccidioides posadasii.
Coccidioidomycosis is an endemic fungal infection that is typically asymptomatic or associated with pulmonary disease. Extrapulmonary disease may involve the skin, bones, or central nervous system, yet endovascular infections are exceedingly rare. We ... | LAMIVUDINE, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC-ND | 34159219 | 20,322,682 | 2021-06 |
What was the outcome of reaction 'Coccidioidomycosis'? | Infected Aneurysm of the Native Aorta due to Coccidioides posadasii.
Coccidioidomycosis is an endemic fungal infection that is typically asymptomatic or associated with pulmonary disease. Extrapulmonary disease may involve the skin, bones, or central nervous system, yet endovascular infections are exceedingly rare. We ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34159219 | 20,322,682 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug-induced liver injury'. | Case report of acute liver injury caused by the eszopiclone in a patient with chronic liver disease.
BACKGROUND
Eszopiclone, sold under the brand name Lunesta, is a new type of non-benzodiazepine hypnotic. Eszopiclone is a zopiclone dextrorotation, which is classified as a cyclopyrrolone. It functions by binding gamma-... | ENTECAVIR, ESZOPICLONE, LECITHIN, TRAZODONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34160387 | 19,519,574 | 2021-06-25 |
What was the administration route of drug 'ENTECAVIR'? | Case report of acute liver injury caused by the eszopiclone in a patient with chronic liver disease.
BACKGROUND
Eszopiclone, sold under the brand name Lunesta, is a new type of non-benzodiazepine hypnotic. Eszopiclone is a zopiclone dextrorotation, which is classified as a cyclopyrrolone. It functions by binding gamma-... | Oral | DrugAdministrationRoute | CC BY | 34160387 | 19,519,574 | 2021-06-25 |
What was the administration route of drug 'ESZOPICLONE'? | Case report of acute liver injury caused by the eszopiclone in a patient with chronic liver disease.
BACKGROUND
Eszopiclone, sold under the brand name Lunesta, is a new type of non-benzodiazepine hypnotic. Eszopiclone is a zopiclone dextrorotation, which is classified as a cyclopyrrolone. It functions by binding gamma-... | Oral | DrugAdministrationRoute | CC BY | 34160387 | 19,519,574 | 2021-06-25 |
What was the administration route of drug 'LECITHIN'? | Case report of acute liver injury caused by the eszopiclone in a patient with chronic liver disease.
BACKGROUND
Eszopiclone, sold under the brand name Lunesta, is a new type of non-benzodiazepine hypnotic. Eszopiclone is a zopiclone dextrorotation, which is classified as a cyclopyrrolone. It functions by binding gamma-... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34160387 | 19,519,574 | 2021-06-25 |
What was the administration route of drug 'TRAZODONE HYDROCHLORIDE'? | Case report of acute liver injury caused by the eszopiclone in a patient with chronic liver disease.
BACKGROUND
Eszopiclone, sold under the brand name Lunesta, is a new type of non-benzodiazepine hypnotic. Eszopiclone is a zopiclone dextrorotation, which is classified as a cyclopyrrolone. It functions by binding gamma-... | Oral | DrugAdministrationRoute | CC BY | 34160387 | 19,519,574 | 2021-06-25 |
What was the dosage of drug 'ESZOPICLONE'? | Case report of acute liver injury caused by the eszopiclone in a patient with chronic liver disease.
BACKGROUND
Eszopiclone, sold under the brand name Lunesta, is a new type of non-benzodiazepine hypnotic. Eszopiclone is a zopiclone dextrorotation, which is classified as a cyclopyrrolone. It functions by binding gamma-... | EACH DAY | DrugDosageText | CC BY | 34160387 | 19,519,574 | 2021-06-25 |
What was the outcome of reaction 'Drug-induced liver injury'? | Case report of acute liver injury caused by the eszopiclone in a patient with chronic liver disease.
BACKGROUND
Eszopiclone, sold under the brand name Lunesta, is a new type of non-benzodiazepine hypnotic. Eszopiclone is a zopiclone dextrorotation, which is classified as a cyclopyrrolone. It functions by binding gamma-... | Recovering | ReactionOutcome | CC BY | 34160387 | 19,519,574 | 2021-06-25 |
What is the weight of the patient? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | 64.4 kg. | Weight | CC BY | 34160410 | 19,610,338 | 2021-06-25 |
What was the administration route of drug 'DOPAMINE HYDROCHLORIDE'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34160410 | 19,610,338 | 2021-06-25 |
What was the administration route of drug 'LIDOCAINE'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34160410 | 19,506,405 | 2021-06-25 |
What was the administration route of drug 'PROPOFOL'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34160410 | 19,506,405 | 2021-06-25 |
What was the dosage of drug 'FENTANYL'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | 50 µg (micrograms). | DrugDosage | CC BY | 34160410 | 19,506,405 | 2021-06-25 |
What was the dosage of drug 'GLYCOPYRRONIUM'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | .2 mg (milligrams). | DrugDosage | CC BY | 34160410 | 19,506,405 | 2021-06-25 |
What was the dosage of drug 'LIDOCAINE'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | 40 mg (milligrams). | DrugDosage | CC BY | 34160410 | 19,506,405 | 2021-06-25 |
What was the dosage of drug 'MIDAZOLAM'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | 2 mg (milligrams). | DrugDosage | CC BY | 34160410 | 19,506,405 | 2021-06-25 |
What was the dosage of drug 'NOREPINEPHRINE'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | RATE OF 0. 5MCG/KG/MIN | DrugDosageText | CC BY | 34160410 | 19,506,405 | 2021-06-25 |
What was the dosage of drug 'PROPOFOL'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | 2.5 TO 3.0MCG/ML | DrugDosageText | CC BY | 34160410 | 19,506,405 | 2021-06-25 |
What was the dosage of drug 'PYRIDOSTIGMINE'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | 10 mg (milligrams). | DrugDosage | CC BY | 34160410 | 19,506,405 | 2021-06-25 |
What was the dosage of drug 'REMIFENTANIL HYDROCHLORIDE'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | 1 TO 3NG/ML | DrugDosageText | CC BY | 34160410 | 19,506,405 | 2021-06-25 |
What was the dosage of drug 'SUGAMMADEX'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | 200 mg (milligrams). | DrugDosage | CC BY | 34160410 | 19,506,405 | 2021-06-25 |
What was the outcome of reaction 'Ventricular tachycardia'? | Ventricular tachycardia of right ventricular outflow tract origin during the perioperative period: A case report.
BACKGROUND
Idiopathic ventricular tachycardia (VT) occurs in individuals without structural abnormalities in the heart, accounts for approximately 10% of total VTs. Furthermore, approximately 70% of idiopat... | Recovered | ReactionOutcome | CC BY | 34160410 | 19,610,338 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatotoxicity'. | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
BACKGROUND
Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a... | CYCLOPHOSPHAMIDE, CYTARABINE, DASATINIB, DEXAMETHASONE, METHOTREXATE, TRAMETINIB | DrugsGivenReaction | CC BY | 34160436 | 19,606,436 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy toxic'. | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
BACKGROUND
Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a... | CYCLOPHOSPHAMIDE, CYTARABINE, DASATINIB, DEXAMETHASONE, METHOTREXATE, TRAMETINIB | DrugsGivenReaction | CC BY | 34160436 | 19,606,436 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
BACKGROUND
Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a... | CYCLOPHOSPHAMIDE, CYTARABINE, DASATINIB, DEXAMETHASONE, METHOTREXATE, TRAMETINIB | DrugsGivenReaction | CC BY | 34160436 | 19,606,436 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
BACKGROUND
Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a... | CYCLOPHOSPHAMIDE, CYTARABINE, DASATINIB, DEXAMETHASONE, METHOTREXATE, TRAMETINIB | DrugsGivenReaction | CC BY | 34160436 | 19,606,436 | 2021-06-25 |
What was the administration route of drug 'DASATINIB'? | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
BACKGROUND
Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a... | Oral | DrugAdministrationRoute | CC BY | 34160436 | 19,606,436 | 2021-06-25 |
What was the administration route of drug 'TRAMETINIB'? | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
BACKGROUND
Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a... | Oral | DrugAdministrationRoute | CC BY | 34160436 | 19,606,436 | 2021-06-25 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
BACKGROUND
Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a... | 300 MG/M2 ON DAY 1 | DrugDosageText | CC BY | 34160436 | 19,606,436 | 2021-06-25 |
What was the dosage of drug 'CYTARABINE'? | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
BACKGROUND
Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a... | 300 MG/M2 ON DAY 1 | DrugDosageText | CC BY | 34160436 | 19,606,436 | 2021-06-25 |
What was the dosage of drug 'DASATINIB'? | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
BACKGROUND
Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a... | 65 MG, QD | DrugDosageText | CC BY | 34160436 | 19,606,436 | 2021-06-25 |
What was the dosage of drug 'DEXAMETHASONE'? | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
BACKGROUND
Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a... | 6 MG/M2 ON DAYS 1 TO 7 EVERY 8 WEEKS | DrugDosageText | CC BY | 34160436 | 19,606,436 | 2021-06-25 |
What was the dosage of drug 'METHOTREXATE'? | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
BACKGROUND
Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a... | 25 MG/M2, QW | DrugDosageText | CC BY | 34160436 | 19,606,436 | 2021-06-25 |
What was the dosage of drug 'TRAMETINIB'? | Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report.
BACKGROUND
Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a... | 0.025 MG/KG, Q4W, ON DAYS 1 TO 14 FOR 18 CYCLES | DrugDosageText | CC BY | 34160436 | 19,606,436 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic failure'. | Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.
BACKGROUND
Veno-occlusive disease (VOD) is characterized by painful hepatomegaly, ascites, weight gain, and jaundice with nonthrombotic, fibrous obliteration of the centrilobular hepatic ve... | CORTICOSTEROID NOS, MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34160449 | 19,528,699 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Venoocclusive disease'. | Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.
BACKGROUND
Veno-occlusive disease (VOD) is characterized by painful hepatomegaly, ascites, weight gain, and jaundice with nonthrombotic, fibrous obliteration of the centrilobular hepatic ve... | PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34160449 | 19,509,554 | 2021-06-25 |
What is the weight of the patient? | Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.
BACKGROUND
Veno-occlusive disease (VOD) is characterized by painful hepatomegaly, ascites, weight gain, and jaundice with nonthrombotic, fibrous obliteration of the centrilobular hepatic ve... | 47.5 kg. | Weight | CC BY | 34160449 | 19,509,554 | 2021-06-25 |
What was the outcome of reaction 'Hepatic failure'? | Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.
BACKGROUND
Veno-occlusive disease (VOD) is characterized by painful hepatomegaly, ascites, weight gain, and jaundice with nonthrombotic, fibrous obliteration of the centrilobular hepatic ve... | Recovered | ReactionOutcome | CC BY | 34160449 | 19,528,699 | 2021-06-25 |
What was the outcome of reaction 'Venoocclusive disease'? | Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.
BACKGROUND
Veno-occlusive disease (VOD) is characterized by painful hepatomegaly, ascites, weight gain, and jaundice with nonthrombotic, fibrous obliteration of the centrilobular hepatic ve... | Recovered | ReactionOutcome | CC BY | 34160449 | 19,509,554 | 2021-06-25 |
What was the outcome of reaction 'Venoocclusive liver disease'? | Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.
BACKGROUND
Veno-occlusive disease (VOD) is characterized by painful hepatomegaly, ascites, weight gain, and jaundice with nonthrombotic, fibrous obliteration of the centrilobular hepatic ve... | Recovered | ReactionOutcome | CC BY | 34160449 | 19,794,648 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Heparin-induced thrombocytopenia'. | Favorable response to second-line atezolizumab and bevacizumab following progression on nivolumab in advanced hepatocellular carcinoma: A case report demonstrating that anti-VEGF therapy overcomes resistance to checkpoint inhibition.
BACKGROUND
Advanced hepatocellular carcinoma (HCC) remains a deadly disease in part du... | FLUOROURACIL, HEPARIN SODIUM, LEUCOVORIN | DrugsGivenReaction | CC BY | 34160456 | 19,596,546 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatocellular carcinoma'. | Favorable response to second-line atezolizumab and bevacizumab following progression on nivolumab in advanced hepatocellular carcinoma: A case report demonstrating that anti-VEGF therapy overcomes resistance to checkpoint inhibition.
BACKGROUND
Advanced hepatocellular carcinoma (HCC) remains a deadly disease in part du... | ATEZOLIZUMAB, BEVACIZUMAB, LENVATINIB, LEUCOVORIN, NIVOLUMAB | DrugsGivenReaction | CC BY | 34160456 | 19,503,210 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Favorable response to second-line atezolizumab and bevacizumab following progression on nivolumab in advanced hepatocellular carcinoma: A case report demonstrating that anti-VEGF therapy overcomes resistance to checkpoint inhibition.
BACKGROUND
Advanced hepatocellular carcinoma (HCC) remains a deadly disease in part du... | ATEZOLIZUMAB, BEVACIZUMAB, LENVATINIB, LEUCOVORIN, NIVOLUMAB | DrugsGivenReaction | CC BY | 34160456 | 19,503,210 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Favorable response to second-line atezolizumab and bevacizumab following progression on nivolumab in advanced hepatocellular carcinoma: A case report demonstrating that anti-VEGF therapy overcomes resistance to checkpoint inhibition.
BACKGROUND
Advanced hepatocellular carcinoma (HCC) remains a deadly disease in part du... | ATEZOLIZUMAB, BEVACIZUMAB, LENVATINIB, LEUCOVORIN, NIVOLUMAB | DrugsGivenReaction | CC BY | 34160456 | 19,503,210 | 2021-06-25 |
What was the dosage of drug 'BEVACIZUMAB'? | Favorable response to second-line atezolizumab and bevacizumab following progression on nivolumab in advanced hepatocellular carcinoma: A case report demonstrating that anti-VEGF therapy overcomes resistance to checkpoint inhibition.
BACKGROUND
Advanced hepatocellular carcinoma (HCC) remains a deadly disease in part du... | UNK, Q3WK | DrugDosageText | CC BY | 34160456 | 19,503,210 | 2021-06-25 |
What was the outcome of reaction 'Heparin-induced thrombocytopenia'? | Favorable response to second-line atezolizumab and bevacizumab following progression on nivolumab in advanced hepatocellular carcinoma: A case report demonstrating that anti-VEGF therapy overcomes resistance to checkpoint inhibition.
BACKGROUND
Advanced hepatocellular carcinoma (HCC) remains a deadly disease in part du... | Recovered | ReactionOutcome | CC BY | 34160456 | 19,596,546 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to bone'. | Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity.
Lung is the most common site of distant metastasis for patients with head and neck squamous cell carcinoma (HNSCC). However, differentiating second primary lung cancers from ... | CARBOPLATIN, CETUXIMAB, FLUOROURACIL | DrugsGivenReaction | CC BY | 34161676 | 20,636,560 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity.
Lung is the most common site of distant metastasis for patients with head and neck squamous cell carcinoma (HNSCC). However, differentiating second primary lung cancers from ... | OLAPARIB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34161676 | 20,202,572 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelofibrosis'. | Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura
Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease characterized by isolated thrombocytopenia. While first-line treatments focus on inhibiting autoantibodies and platelet destruction,... | ELTROMBOPAG | DrugsGivenReaction | CC BY | 34162173 | 20,886,519 | 2021-08-25 |
What was the dosage of drug 'ELTROMBOPAG'? | Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura
Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease characterized by isolated thrombocytopenia. While first-line treatments focus on inhibiting autoantibodies and platelet destruction,... | AS SECOND-LINE OR THIRD-LINE THERAPY | DrugDosageText | CC BY | 34162173 | 20,886,519 | 2021-08-25 |
What was the administration route of drug 'LENALIDOMIDE'? | Intravascular lymphoma presenting with hypoxaemia, platypnoea and lactic acidosis.
Intravascular large B-cell lymphoma (IVLBCL) is an aggressive and rare type of diffuse extranodal B-cell lymphoma. Diagnosis and treatment are challenging and clinical presentation is variable. Physicians should be aware of this rare but... | Oral | DrugAdministrationRoute | CC BY-NC | 34162604 | 20,389,351 | 2021-06-23 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Intravascular lymphoma presenting with hypoxaemia, platypnoea and lactic acidosis.
Intravascular large B-cell lymphoma (IVLBCL) is an aggressive and rare type of diffuse extranodal B-cell lymphoma. Diagnosis and treatment are challenging and clinical presentation is variable. Physicians should be aware of this rare but... | 750 MILLIGRAM/SQ. METER | DrugDosageText | CC BY-NC | 34162604 | 20,389,351 | 2021-06-23 |
What was the dosage of drug 'DOXORUBICIN'? | Intravascular lymphoma presenting with hypoxaemia, platypnoea and lactic acidosis.
Intravascular large B-cell lymphoma (IVLBCL) is an aggressive and rare type of diffuse extranodal B-cell lymphoma. Diagnosis and treatment are challenging and clinical presentation is variable. Physicians should be aware of this rare but... | 50 MILLIGRAM/SQ. METER | DrugDosageText | CC BY-NC | 34162604 | 20,389,351 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Posterior reversible encephalopathy syndrome'. | Combined Liver-Lung-Kidney Transplant in a Patient with Cystic Fibrosis.
BACKGROUND Individuals with cystic fibrosis (CF) constituted approximately 10% of organ transplants in 2019, with the majority of transplants consisting of bilateral lung transplant. Multiorgan transplantation in individuals with cystic fibrosis (... | AMPHOTERICIN B, BASILIXIMAB, MEROPENEM, METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34162826 | 19,580,702 | 2021-06-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.
Background: Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory distress syndrome-coronavirus-2 (SARS-CoV-2), is primarily a respiratory infection but has been recently associated with a variety of neurological symptoms. We p... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34163427 | 20,389,249 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.
Background: Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory distress syndrome-coronavirus-2 (SARS-CoV-2), is primarily a respiratory infection but has been recently associated with a variety of neurological symptoms. We p... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34163427 | 20,389,249 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.
Background: Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory distress syndrome-coronavirus-2 (SARS-CoV-2), is primarily a respiratory infection but has been recently associated with a variety of neurological symptoms. We p... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34163427 | 20,389,249 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dizziness'. | The Promising Effect of Nerve Decompression in Trigeminal Autonomic Cephalalgias: Report of Case Series.
Trigeminal Autonomic Cephalalgias (TAC) are excruciating headaches with limited treatment options. The chronic forms of TACs, including chronic cluster, chronic paroxysmal hemicrania, and hemicrania continua, are di... | GABAPENTIN, INDOMETHACIN, MELATONIN, TOPIRAMATE, VALPROIC ACID | DrugsGivenReaction | CC BY | 34163429 | 20,459,436 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspepsia'. | The Promising Effect of Nerve Decompression in Trigeminal Autonomic Cephalalgias: Report of Case Series.
Trigeminal Autonomic Cephalalgias (TAC) are excruciating headaches with limited treatment options. The chronic forms of TACs, including chronic cluster, chronic paroxysmal hemicrania, and hemicrania continua, are di... | GABAPENTIN, INDOMETHACIN, MELATONIN, TOPIRAMATE, VALPROIC ACID | DrugsGivenReaction | CC BY | 34163429 | 20,459,436 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | The Promising Effect of Nerve Decompression in Trigeminal Autonomic Cephalalgias: Report of Case Series.
Trigeminal Autonomic Cephalalgias (TAC) are excruciating headaches with limited treatment options. The chronic forms of TACs, including chronic cluster, chronic paroxysmal hemicrania, and hemicrania continua, are di... | CELECOXIB, GABAPENTIN, INDOMETHACIN, LAMOTRIGINE, MELATONIN, TOPIRAMATE | DrugsGivenReaction | CC BY | 34163429 | 20,458,998 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | The Promising Effect of Nerve Decompression in Trigeminal Autonomic Cephalalgias: Report of Case Series.
Trigeminal Autonomic Cephalalgias (TAC) are excruciating headaches with limited treatment options. The chronic forms of TACs, including chronic cluster, chronic paroxysmal hemicrania, and hemicrania continua, are di... | CELECOXIB, GABAPENTIN, INDOMETHACIN, LAMOTRIGINE, MELATONIN, TOPIRAMATE | DrugsGivenReaction | CC BY | 34163429 | 20,458,998 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.
The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with ... | HYDROXYCHLOROQUINE, MOXIFLOXACIN | DrugsGivenReaction | CC BY | 34164411 | 19,967,071 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.
The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with ... | BELIMUMAB, CEFTAZIDIME, DOPAMINE HYDROCHLORIDE, HEPARIN SODIUM, HYDROXYCHLOROQUINE, LEVOFLOXACIN, METHYLPREDNISOLONE, MOXIFLOXACIN, NOREPINEPHRINE, TOCILIZUMAB, TOFACITINIB | DrugsGivenReaction | CC BY | 34164411 | 19,976,000 | 2021 |
What was the dosage of drug 'BELIMUMAB'? | Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.
The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with ... | 400 MILLIGRAM, ON 4 MAY | DrugDosageText | CC BY | 34164411 | 19,976,000 | 2021 |
What was the dosage of drug 'DOPAMINE HYDROCHLORIDE'? | Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.
The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with ... | 3.7 MICROGRAM/KILOGRAM | DrugDosageText | CC BY | 34164411 | 19,976,000 | 2021 |
What was the dosage of drug 'HYDROXYCHLOROQUINE'? | Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.
The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with ... | 400 MILLIGRAM | DrugDosageText | CC BY | 34164411 | 19,976,000 | 2021 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.
The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with ... | UNK, ON 27 APRIL AND 4 MAY | DrugDosageText | CC BY | 34164411 | 19,976,000 | 2021 |
What was the dosage of drug 'TOCILIZUMAB'? | Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.
The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with ... | 400 MILLIGRAM; ON 13 APRIL AND 4 MAY | DrugDosageText | CC BY | 34164411 | 19,976,000 | 2021 |
What was the dosage of drug 'TOFACITINIB'? | Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.
The COVID-19 pandemic has caused multiple deaths worldwide. Since no specific therapies are currently available, treatment for critically ill patients with ... | 5 MILLIGRAM, ON 05 AND 13 APRIL | DrugDosageText | CC BY | 34164411 | 19,976,000 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis ulcerative'. | Infliximab Therapy for Children with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down Strategy.
OBJECTIVE
We aimed to investigate clinical outcomes between top-down (TD) and conventional step-up (SU) therapies in pediatric patients with moderate to severe ulcerative colitis (UC).
METHODS
All patient... | INFLIXIMAB | DrugsGivenReaction | CC BY-NC | 34164958 | 19,518,559 | 2021-07 |
What was the administration route of drug 'INFLIXIMAB'? | Infliximab Therapy for Children with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down Strategy.
OBJECTIVE
We aimed to investigate clinical outcomes between top-down (TD) and conventional step-up (SU) therapies in pediatric patients with moderate to severe ulcerative colitis (UC).
METHODS
All patient... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34164958 | 19,518,559 | 2021-07 |
What was the dosage of drug 'INFLIXIMAB'? | Infliximab Therapy for Children with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down Strategy.
OBJECTIVE
We aimed to investigate clinical outcomes between top-down (TD) and conventional step-up (SU) therapies in pediatric patients with moderate to severe ulcerative colitis (UC).
METHODS
All patient... | 5 MG/KG FOR 0, 2, AND 6 WEEKS (REPEATED EVERY 8 WEEKS FROM WEEK 14) | DrugDosageText | CC BY-NC | 34164958 | 19,518,559 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Altered state of consciousness'. | Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.
We explored the use of pulverized medication as a new method to prevent intentional drug overdose.
This case study presents data obtained from the medical records of two female patients, aged 19 and 27 yea... | BROTIZOLAM, LEVOMEPROMAZINE, RISPERIDONE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34165255 | 20,889,906 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypersomnia'. | Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.
We explored the use of pulverized medication as a new method to prevent intentional drug overdose.
This case study presents data obtained from the medical records of two female patients, aged 19 and 27 yea... | BROTIZOLAM, LEVOMEPROMAZINE, RISPERIDONE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34165255 | 20,889,906 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional overdose'. | Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.
We explored the use of pulverized medication as a new method to prevent intentional drug overdose.
This case study presents data obtained from the medical records of two female patients, aged 19 and 27 yea... | BROTIZOLAM, LEVOMEPROMAZINE, RISPERIDONE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34165255 | 20,896,328 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.
We explored the use of pulverized medication as a new method to prevent intentional drug overdose.
This case study presents data obtained from the medical records of two female patients, aged 19 and 27 yea... | ALPRAZOLAM, VALPROIC ACID | DrugsGivenReaction | CC BY | 34165255 | 20,898,516 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.
We explored the use of pulverized medication as a new method to prevent intentional drug overdose.
This case study presents data obtained from the medical records of two female patients, aged 19 and 27 yea... | BROTIZOLAM, LEVOMEPROMAZINE, RISPERIDONE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34165255 | 20,889,906 | 2021-09 |
What was the administration route of drug 'RISPERIDONE'? | Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.
We explored the use of pulverized medication as a new method to prevent intentional drug overdose.
This case study presents data obtained from the medical records of two female patients, aged 19 and 27 yea... | Endocervical | DrugAdministrationRoute | CC BY | 34165255 | 20,889,906 | 2021-09 |
What was the dosage of drug 'ALPRAZOLAM'? | Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.
We explored the use of pulverized medication as a new method to prevent intentional drug overdose.
This case study presents data obtained from the medical records of two female patients, aged 19 and 27 yea... | UNK (0.8MG X 16 TABLETS) | DrugDosageText | CC BY | 34165255 | 20,898,516 | 2021-09 |
What was the dosage of drug 'VALPROIC ACID'? | Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.
We explored the use of pulverized medication as a new method to prevent intentional drug overdose.
This case study presents data obtained from the medical records of two female patients, aged 19 and 27 yea... | UNK (200MG X 82 TABLETS) | DrugDosageText | CC BY | 34165255 | 20,898,516 | 2021-09 |
What was the outcome of reaction 'Intentional overdose'? | Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.
We explored the use of pulverized medication as a new method to prevent intentional drug overdose.
This case study presents data obtained from the medical records of two female patients, aged 19 and 27 yea... | Recovered | ReactionOutcome | CC BY | 34165255 | 20,889,906 | 2021-09 |
What was the outcome of reaction 'Product use issue'? | Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.
We explored the use of pulverized medication as a new method to prevent intentional drug overdose.
This case study presents data obtained from the medical records of two female patients, aged 19 and 27 yea... | Recovered | ReactionOutcome | CC BY | 34165255 | 20,889,906 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Large intestinal ulcer perforation'. | Colonic Perforation After Treatment With Nivolumab in Esophageal Cancer: A Case Report.
With the advent of checkpoint inhibitors, it has opened up opportunities for numerous cancer patients. However, as is the case with every treatment, complications need to be weighed. Gastrointestinal adverse effects, such as diarrhe... | NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 34167190 | 19,658,095 | 2021-07 |
What was the dosage of drug 'NIVOLUMAB'? | Colonic Perforation After Treatment With Nivolumab in Esophageal Cancer: A Case Report.
With the advent of checkpoint inhibitors, it has opened up opportunities for numerous cancer patients. However, as is the case with every treatment, complications need to be weighed. Gastrointestinal adverse effects, such as diarrhe... | 3 MILLIGRAM/KILOGRAM, Q2WK | DrugDosageText | CC BY-NC | 34167190 | 19,658,095 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | A New Treatment Strategy for Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is an aggressive and extremely fatal subtype of T-cell acute lymphoblastic leukemia (T-ALL), characterized by the similar transcriptional a... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, DOXORUBICIN, VINCRISTINE | DrugsGivenReaction | CC BY-NC | 34168464 | 19,613,122 | 2021 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | A New Treatment Strategy for Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is an aggressive and extremely fatal subtype of T-cell acute lymphoblastic leukemia (T-ALL), characterized by the similar transcriptional a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34168464 | 19,613,122 | 2021 |
What was the administration route of drug 'DOXORUBICIN'? | A New Treatment Strategy for Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is an aggressive and extremely fatal subtype of T-cell acute lymphoblastic leukemia (T-ALL), characterized by the similar transcriptional a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34168464 | 19,613,122 | 2021 |
What was the administration route of drug 'VINCRISTINE'? | A New Treatment Strategy for Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is an aggressive and extremely fatal subtype of T-cell acute lymphoblastic leukemia (T-ALL), characterized by the similar transcriptional a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34168464 | 19,613,122 | 2021 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | A New Treatment Strategy for Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is an aggressive and extremely fatal subtype of T-cell acute lymphoblastic leukemia (T-ALL), characterized by the similar transcriptional a... | SIX DOSES OVER 3 HOURS EVERY 12 HOURS ON DAYS 1 THROUGH 3 | DrugDosageText | CC BY-NC | 34168464 | 19,613,122 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | A New Treatment Strategy for Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is an aggressive and extremely fatal subtype of T-cell acute lymphoblastic leukemia (T-ALL), characterized by the similar transcriptional a... | ON DAYS 1 THROUGH 4 AND 11 THROUGH 14 | DrugDosageText | CC BY-NC | 34168464 | 19,613,122 | 2021 |
What was the dosage of drug 'DOXORUBICIN'? | A New Treatment Strategy for Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is an aggressive and extremely fatal subtype of T-cell acute lymphoblastic leukemia (T-ALL), characterized by the similar transcriptional a... | ON DAY 4 | DrugDosageText | CC BY-NC | 34168464 | 19,613,122 | 2021 |
What was the dosage of drug 'VINCRISTINE'? | A New Treatment Strategy for Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is an aggressive and extremely fatal subtype of T-cell acute lymphoblastic leukemia (T-ALL), characterized by the similar transcriptional a... | ON DAYS 4 AND 11 | DrugDosageText | CC BY-NC | 34168464 | 19,613,122 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Epileptic Phenotype and Cannabidiol Efficacy in a Williams-Beuren Syndrome Patient With Atypical Deletion: A Case Report.
Epilepsy is a rare clinical manifestation in Williams-Beuren syndrome patients. However, some studies report the presence of infantile spasms and epilepsy in patients carrying larger deletions. Here... | CANNABIDIOL, CARBAMAZEPINE, CLOBAZAM, CLONAZEPAM, DIAZEPAM, ETHOSUXIMIDE, HYDROCORTISONE, LACOSAMIDE, LAMOTRIGINE, LEVETIRACETAM, NITRAZEPAM, OXCARBAZEPINE, PERAMPANEL, PHENOBARBITAL, PREGABALIN, PRIMIDONE, RUFINAMIDE, TOPIRAMATE, VALPROATE SODIUM, VIGABATRIN | DrugsGivenReaction | CC BY | 34168609 | 20,546,498 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Epileptic Phenotype and Cannabidiol Efficacy in a Williams-Beuren Syndrome Patient With Atypical Deletion: A Case Report.
Epilepsy is a rare clinical manifestation in Williams-Beuren syndrome patients. However, some studies report the presence of infantile spasms and epilepsy in patients carrying larger deletions. Here... | CARBAMAZEPINE, CLOBAZAM, CLONAZEPAM, LACOSAMIDE, LAMOTRIGINE, LEVETIRACETAM, NITRAZEPAM, OXCARBAZEPINE, PHENOBARBITAL, PREGABALIN, TOPIRAMATE, VALPROIC ACID, VIGABATRIN | DrugsGivenReaction | CC BY | 34168609 | 20,580,267 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.